These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 18221198)
1. Therapeutic perspectives in Alzheimer's disease. Tschäpe JA; Hartmann T Recent Pat CNS Drug Discov; 2006 Jan; 1(1):119-27. PubMed ID: 18221198 [TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
3. Disease-modifying therapies in Alzheimer's disease: how far have we come? Hüll M; Berger M; Heneka M Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302 [TBL] [Abstract][Full Text] [Related]
10. Progress in the development of new drugs in Alzheimer's disease. Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520 [TBL] [Abstract][Full Text] [Related]
12. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease. Moussa CE Expert Opin Investig Drugs; 2017 Oct; 26(10):1131-1136. PubMed ID: 28817311 [TBL] [Abstract][Full Text] [Related]
13. The past, present, and future of disease-modifying therapies for Alzheimer's disease. Suzuki K; Iwata A; Iwatsubo T Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies. Christensen DD CNS Spectr; 2007 Feb; 12(2):113-6, 119-23. PubMed ID: 17277711 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for Alzheimer's disease in clinical trials. Godyń J; Jończyk J; Panek D; Malawska B Pharmacol Rep; 2016 Feb; 68(1):127-38. PubMed ID: 26721364 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond? Mullane K; Williams M Biochem Pharmacol; 2013 Feb; 85(3):289-305. PubMed ID: 23178653 [TBL] [Abstract][Full Text] [Related]
18. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease. Höglund K; Blennow K CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol and Alzheimer's disease: statins, cholesterol depletion in APP processing and Abeta generation. Hartman T Subcell Biochem; 2005; 38():365-80. PubMed ID: 15709489 [TBL] [Abstract][Full Text] [Related]